A recent report published by Infinium Global Research on inhalation therapy nebulizer market provides in-depth analysis of segments and sub-segments in the global as well as regional inhalation therapy nebulizer market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional inhalation therapy nebulizer market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global inhalation therapy nebulizer market. According to the report, the global inhalation therapy nebulizer market is projected to grow at a CAGR of 6.2% over the forecast period of 2018-2024.
Inhalation therapies are a group of respiratory, or breathing, treatments designed to help restore or improve breathing function in patients with a variety of diseases, conditions, or injuries. An inhalation therapy nebulizer is a medical device used in inhalation therapy for administering the required drug. It is convenient when a large dose of an inhalation medication is needed. It is also used in a variety of medication treatment such as treating asthma symptoms and for immediate relief. The nebulizer can be easier to use compared to MDIs, especially for small children, infants and anyone who has difficulty using an asthma inhaler. Nebulizer reduces the risk associated with the side effects of taking high doses of prescribed medicines. The nebulizer is administered to treat asthma, cystic fibrosis, bronchitis, common cold, COPD, and other respiratory diseases or disorder. The various types of the nebulizer in the market includes Ultrasonic wave nebulizer, pneumatic nebulizer, and mesh nebulizers.
The increasing prevalence of respiratory disorder such as chronic obstructive pulmonary disease (COPD), asthma, obstructive lung disorders over the globe is escalating the growth of inhalation therapy nebulizer market. According to WHO, 235 million people suffer from asthma worldwide. Asthma is one of the common chronic breathing diseases. Additionally, WHO predicts that COPD will become the third leading cause of death worldwide by 2030. Due to its benefits such as ease of use compared to the dry powder of an inhaler, nebulizers are widely used for the treatment of respiratory diseases. Moreover, increasing air pollution across the globe and growing geriatric population with various diseases are supporting factor driving the growth of inhalation therapy nebulizer market. On the other hand, the risk of drug loss caused by nebulizer during conversion of the drug into the mist is one of the major concern could hamper the growth of inhalation therapy nebulizer market. Going further, the use of inhalation therapy nebulizer in other diseases such as diabetes and migraine is expected to provide growth opportunities for Inhalation Therapy Nebulizer Market.
Among the region, North America accounted to be the largest share in the global inhalation therapy nebulizer market. High prevalence of COPD and asthma in adults and children’s boost the demand of inhalation therapy nebulizers in the U.S. Additionally well-developed healthcare infrastructures and technological advancement are some factors boost the demand of market in North America region. Europe is expected to witness substantial growth in the inhalation therapy nebulizer market during the forecast period. Rising awareness regarding the use of nebulizers and favorable health policies are some factors fuelling the demand for the inhalation therapy nebulizer market in the Europe region during the forecast period. The Asia Pacific is expected to be the fastest growing region during the forecast period. Growing geriatric population coupled with high cases of respiratory disorder is the main factor responsible for the growth of inhalation therapy nebulizer market.
The report on global inhalation therapy nebulizer market covers segments such as type, applications, and end-user. On the basis of type, the sub-markets include ultrasonic nebulizers, and atomizer jet. On the basis of applications, the sub-markets include asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, nasal congestion, and other respiratory diseases or disorders. On the basis of end-user, the sub-markets include hospitals, ambulatory surgery centers, home care centers, and clinics.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region, as it is the largest market in this region. The Asia-pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China.
The report provides profiles of the companies in the market such as 3M, AptarGroup, Inc., Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., OMRON Corporation, DeVilbiss Healthcare LLC, PARI GmbH Spezialisten für effektive Inhalation, Air Liquide Medical Systems, A&D Company, GF HEALTH PRODUCTS, INC., Vyaire Medical Inc., and Trudell Medical International.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of inhalation therapy nebulizer market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter